Histologically Verified Biliary Invasion was Associated with Impaired Liver Recurrence-Free Survival in Resected Colorectal Cancer Liver Metastases

Microscopic biliary and perineural invasion and clinical outcome after neoadjuvant bevacizumab-based chemotherapy and liver resection in patients with colorectal liver metastases

(2018) Judith Stift et al.   EJSO

Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer

(2017) Alan P. Venook et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

(2016) E. Van Cutsem et al.   ANNALS OF ONCOLOGY

Can KRAS and BRAF mutations limit the benefit of liver resection in metastatic colorectal cancer patients? A systematic review and meta-analysis

(2016) Francesco Passiglia et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Lymphatic Invasion is an Independent Adverse Prognostic Factor in Patients with Colorectal Liver Metastasis

(2015) Jannemarie A. M. de Ridder et al.   ANNALS OF SURGICAL ONCOLOGY

BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection

(2015) M Schirripa et al.   BRITISH JOURNAL OF CANCER

Meta-analysis ofKRASmutations and survival after resection of colorectal liver metastases

(2015) K. W. Brudvik et al.   BRITISH JOURNAL OF SURGERY

Managing synchronous liver metastases from colorectal cancer: A multidisciplinary international consensus

(2015) René Adam et al.   CANCER TREATMENT REVIEWS

Role of neoadjuvant chemotherapy in resectable synchronous colorectal liver metastasis; An international multi-center data analysis using LiverMetSurvey

(2015) Glenn K. Bonney et al.   JOURNAL OF SURGICAL ONCOLOGY

Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases

(2015) Jon-Helge Angelsen et al.   World Journal of Surgical Oncology

Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study)†

(2014) G. Folprecht et al.   ANNALS OF ONCOLOGY

Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial

(2014) T. Gruenberger et al.   ANNALS OF ONCOLOGY

KRASmutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases

(2014) Nancy E. Kemeny et al.   CANCER

Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial

(2014) John Primrose et al.   LANCET ONCOLOGY

Beyond KRAS: Predictive factors of the efficacy of anti-EGFR monoclonal antibodies in the treatment of metastatic colorectal cancer

(2014) Alfonso De Stefano   WORLD JOURNAL OF GASTROENTEROLOGY

Intrahepatic Lymphatic Invasion but not Vascular Invasion is a Major Prognostic Factor after Resection of Colorectal Cancer Liver Metastases

(2014) Renato Micelli Lupinacci et al.   WORLD JOURNAL OF SURGERY

Critical review of the prognostic significance of pathological variables in patients undergoing resection for colorectal liver metastases

(2014) Dhanwant Gomez et al.   HPB

Surgery for colorectal liver metastases: The evolution of determining prognosis

(2014) Gaya Spolverato   World Journal of Gastrointestinal Oncology

Early Recurrence After Liver Resection for Colorectal Metastases: Risk Factors, Prognosis, and Treatment. A LiverMetSurvey-Based Study of 6,025 Patients

(2013) Luca Viganò et al.   ANNALS OF SURGICAL ONCOLOGY

Prognostic Factors and Survival after Resection of Colorectal Liver Metastasis in the Era of Preoperative Chemotherapy: An 11-Year Single-Centre Study

(2013) S.K.P. John et al.   DIGESTIVE SURGERY

Histopathological evaluation of resected colorectal cancer liver metastases: what should be done?

(2013) Nikki Knijn et al.   HISTOPATHOLOGY

Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial

(2013) Bernard Nordlinger et al.   LANCET ONCOLOGY

Prognostic significance of early recurrence: a conditional survival analysis in patients with resected colorectal liver metastasis

(2013) Marcus C.B. Tan et al.   HPB

Detailed Pathologic Characteristics of the Primary Colorectal Tumor Independently Predict Outcome after Hepatectomy for Metastases

(2012) Kenneth Cardona et al.   ANNALS OF SURGICAL ONCOLOGY

Chemotherapy for the conversion of unresectable colorectal cancer liver metastases to resection

(2010) Derek G. Power et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Adjuvant Chemotherapy After Potentially Curative Resection of Metastases From Colorectal Cancer: A Pooled Analysis of Two Randomized Trials

(2008) Emmanuel Mitry et al.   JOURNAL OF CLINICAL ONCOLOGY